Changes to Facebook’s Comment Policies to Affect Social Media Practices for Pharmaceutical Companies

Facebook, the ubiquitous social media platform, recently announced that, as of August 15, 2011, pharmaceutical companies will be unable to disable the comment feature on their pages, and all pre-existing pages for pharmaceutical brand companies will be required to allow comments on their pages after August 15. Subject to Facebook approval on a case-by-case basis, any branded pages solely dedicated to a prescription drug may continue to have the commenting feature removed.

Click the link below to read the full alert.